Cipla launches quality-assured Rectal Artesunate Suppositories for severe malaria in young children
Cipla Ltd, a global pharmaceutical company, and Medicines for Malaria Venture (MMV) announce the launch…
Cipla Ltd, a global pharmaceutical company, and Medicines for Malaria Venture (MMV) announce the launch…
International researchers on Monday (30 May 2017) launched a new computing technology to fight hunger…
Medical experts have urged the government to include the rotavirus vaccine in the National Immunisation…
Specific bacteria living in the human vagina may play a previously unrecognised role in the…
The first phase 3 clinical trial of a long-acting injectable drug to block transmission of…
We live in an urban century. Already more than 50% of the global population lives…
The World Health Organization’s (WHO) World Malaria Report 2016 reveals that children and pregnant women…
After decades of shadowboxing with the human immunodeficiency virus, researchers were encouraged four years ago…
The next Ebola outbreak could have a prime-boost vaccine available, particularly for health workers and vulnerable…
Unequal access to health services and poor quality care for pregnant women is hampering progress…